{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:06:45Z","timestamp":1778821605073,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["268555672 \\u2013 SFB 1213"],"award-info":[{"award-number":["268555672 \\u2013 SFB 1213"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vph.2024.107379","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T03:47:07Z","timestamp":1715831227000},"page":"107379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"155","author":[{"given":"Beate Christiane","family":"Schlueter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Quanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Baldauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khodr","family":"Tello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Grimminger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein-Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Weissmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph Theo","family":"Schermuly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2024.107379_bb0005","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2024.107379_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024969","article-title":"Mortality in pulmonary arterial hypertension in the modern era: early insights from the Pulmonary Hypertension Association registry","volume":"11","author":"Chang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2024.107379_bb0015","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2024.107379_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1164\/rccm.201606-1226PP","article-title":"Translational advances in the field of pulmonary hypertension. from cancer biology to new pulmonary arterial hypertension therapeutics. targeting cell growth and proliferation signaling hubs","volume":"195","author":"Pullamsetti","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2024.107379_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2024.107379_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12039","article-title":"Proteomics discovery of pulmonary hypertension biomarkers: insulin-like growth factor binding proteins are associated with disease severity","volume":"12","author":"Nies","year":"2022","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.vph.2024.107379_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14017431.2020.1782977","article-title":"Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension","volume":"55","author":"Bouzina","year":"2021","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.vph.2024.107379_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.vph.2024.107379_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr. rev."},{"key":"10.1016\/j.vph.2024.107379_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1126\/science.3563497","article-title":"Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus","volume":"236","author":"Han","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.vph.2024.107379_bb0055","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1210\/endo-120-4-1279","article-title":"Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat","volume":"120","author":"Murphy","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2024.107379_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2024.107379_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/2211-5463.12369","article-title":"miR-322-5p targets IGF-1 and is suppressed in the heart of rats with pulmonary hypertension","volume":"8","author":"Connolly","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.vph.2024.107379_bb0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1165\/rcmb.2015-0388OC","article-title":"Smooth muscle insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice","volume":"55","author":"Sun","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.vph.2024.107379_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/cvr\/cvw065","article-title":"miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach","volume":"111","author":"Shi","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2024.107379_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vph.2024.107379_bb0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/PL00000744","article-title":"Structure and function of the type 1 insulin-like growth factor receptor","volume":"57","author":"Adams","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.vph.2024.107379_bb0095","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/physrev.1996.76.4.1005","article-title":"Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors","volume":"76","author":"Stewart","year":"1996","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2359","article-title":"Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer","volume":"6","author":"Clemmons","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2024.107379_bb0105","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"Livingstone","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.vph.2024.107379_bb0110","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0115","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0120","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0125","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0006-291X(86)80313-8","article-title":"Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins","volume":"139","author":"Baxter","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2024.107379_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1651-2227.1991.tb17983.x","article-title":"Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability","volume":"372","author":"Baxter","year":"1991","journal-title":"Acta Paediatr. Scand.Suppl."},{"key":"10.1016\/j.vph.2024.107379_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"Baxter","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.vph.2024.107379_bb0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.beem.2015.07.002","article-title":"Physiology and pathophysiology of IGFBP-1 and IGFBP-2 - consensus and dissent on metabolic control and malignant potential","volume":"29","author":"Hoeflich","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2024.107379_bb0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cytogfr.2014.12.001","article-title":"IGFBP-2: the dark horse in metabolism and cancer","volume":"26","author":"Russo","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0150","first-page":"813","article-title":"IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications","volume":"13","author":"Lin","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.vph.2024.107379_bb0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","article-title":"Insulin-like growth factors and cancer","volume":"3","author":"F\u00fcrstenberger","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.vph.2024.107379_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12079-015-0261-2","article-title":"IGFBP-2 - taking the lead in growth, metabolism and cancer","volume":"9","author":"Yau","year":"2015","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.vph.2024.107379_bb0165","article-title":"Cancer and pulmonary hypertension: learning lessons and real-life interplay","volume":"2020","author":"Pullamsetti","year":"2020","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.vph.2024.107379_bb0170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200709-1369PP","article-title":"The cancer paradigm of severe pulmonary arterial hypertension","volume":"178","author":"Rai","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2024.107379_bb0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/2045893217701438","article-title":"The cancer theory of pulmonary arterial hypertension","volume":"7","author":"Boucherat","year":"2017","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.vph.2024.107379_bb0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1183\/09059180.00007513","article-title":"Pathogenesis of pulmonary arterial hypertension: lessons from cancer","volume":"22","author":"Guignabert","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12916-020-01734-3","article-title":"Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival","volume":"18","author":"Yang","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.vph.2024.107379_bb0190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(17)30161-3","article-title":"Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study","volume":"5","author":"Rhodes","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.vph.2024.107379_bb0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.resp.2003.10.003","article-title":"Basic features of hypoxic pulmonary vasoconstriction in mice","volume":"139","author":"Weissmann","year":"2004","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.vph.2024.107379_bb0200","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/s41467-019-10135-x","article-title":"Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension","volume":"10","author":"Weiss","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vph.2024.107379_bb0205","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2024.107379_bb0210","doi-asserted-by":"crossref","first-page":"32419","DOI":"10.1074\/jbc.C100299200","article-title":"Identification of a nonpeptide ligand that releases bioactive insulin-like growth factor-I from its binding protein complex","volume":"276","author":"Liu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2024.107379_bb0215","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2024.107379_bb0220","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41390-020-01113-x","article-title":"Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival","volume":"88","author":"Griffiths","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.vph.2024.107379_bb0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2017-00908","article-title":"What happened to the IGF binding proteins?","volume":"159","author":"Bach","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2024.107379_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(08)60444-6","article-title":"Insulin-like growth factor binding proteins","volume":"47","author":"Rechler","year":"1993","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.vph.2024.107379_bb0235","first-page":"80","article-title":"Nutritional regulation of the insulin-like growth factors","volume":"15","author":"Thissen","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178656","article-title":"Effect of food intake on 92 biomarkers for cardiovascular disease","volume":"12","author":"Dencker","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vph.2024.107379_bb0245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0006-291X(88)80824-6","article-title":"Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts","volume":"156","author":"de Mellow","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2024.107379_bb0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mrrev.2016.08.007","article-title":"Insulin-like growth factor (IGF) axis in cancerogenesis","volume":"772","author":"Kasprzak","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.vph.2024.107379_bb0255","first-page":"3915","article-title":"Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2","volume":"59","author":"Feldser","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.vph.2024.107379_bb0260","doi-asserted-by":"crossref","first-page":"L489","DOI":"10.1152\/ajplung.90488.2008","article-title":"NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3","volume":"296","author":"Ismail","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.vph.2024.107379_bb0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/en.2008-0657","article-title":"Hypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activity","volume":"150","author":"Seferovic","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2024.107379_bb0270","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0021-9258(18)54050-3","article-title":"Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101","volume":"268","author":"Jones","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2024.107379_bb0275","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/db11-0963","article-title":"Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis","volume":"61","author":"Rajwani","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2024.107379_bb0280","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2011-01-331876","article-title":"IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells","volume":"118","author":"Huynh","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vph.2024.107379_bb0285","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/endrev\/bnad008","article-title":"Signaling pathways of the insulin-like growth factor binding proteins","volume":"44","author":"Baxter","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2024.107379_bb0290","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/onc.2015.131","article-title":"IGFBP2 potentiates nuclear EGFR-STAT3 signaling","volume":"35","author":"Chua","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.vph.2024.107379_bb0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.canlet.2020.02.036","article-title":"IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma","volume":"477","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.vph.2024.107379_bb0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.200811-1682OC","article-title":"Role of epidermal growth factor inhibition in experimental pulmonary hypertension","volume":"181","author":"Dahal","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2024.107379_bb0305","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1165\/rcmb.2019-0431OC","article-title":"Targeting jak-stat signaling in experimental pulmonary hypertension","volume":"64","author":"Yerabolu","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:07:19Z","timestamp":1778818039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"alternative-id":["S1537189124001058"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107379","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107379"}}